Madrigal director Reed granted RSUs, stock options
MADRIGAL PHARMACEUTICALS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported equity compensation grants to director John C. Reed. He received 647 shares of Common Stock as restricted stock units that vest 50% on August 15, 2027 and 50% on August 15, 2028, subject to continued service. He also received a stock option for 1,078 shares at an exercise price of $507.56 per share, expiring August 15, 2036, vesting 50% on August 15, 2027 and 12.5% at the end of each successive three-month period for four periods thereafter, contingent on continued service.
Insider Trade Summary
Grant/Award: 1,725 shares
Grant/Award
2 txns
Insider
REED JOHN C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 1,078 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 647 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,078 contracts (Direct);
Common Stock — 647 shares (Direct)
Footnotes (2)
- F1. Represents a grant of restricted stock units which vest as to 50% of the shares on each of August 15, 2027 and August 15, 2028, provided the Reporting Person continues in service with the Issuer on each such date.
- F2. The option vests as to 50% of the shares on the first anniversary of the date of grant (August 15, 2027), and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period for four successive three-month periods, provided the Reporting Person continues in service with the Issuer on each such date.
Key Figures
Restricted stock units granted: 647 shares
Option shares granted: 1,078 shares
Option exercise price: $507.56 per share
+3 more
6 metrics
Restricted stock units granted
647 shares
Grant of Common Stock RSUs to John C. Reed on August 15, 2026
Option shares granted
1,078 shares
Stock Option (Right to Buy) granted to John C. Reed on August 15, 2026
Option exercise price
$507.56 per share
Exercise price for 1,078-share stock option grant
Option expiration date
August 15, 2036
Expiration of stock option granted to John C. Reed
RSU vesting dates
August 15, 2027 and August 15, 2028
Each date covers 50% of the 647 RSU shares
Initial option vesting
50% on August 15, 2027
First tranche of vesting for 1,078-share stock option
Key Terms
restricted stock units, Stock Option (Right to Buy, exercise price, vesting
4 terms
restricted stock units financial
"Represents a grant of restricted stock units which vest as to 50% of the shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy financial
"security_title": "Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price": "507.5600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests as to 50% of the shares on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did MDGL director John C. Reed report on this Form 4?
John C. Reed reported two equity grants from Madrigal Pharmaceuticals: a grant of 647 restricted stock units of Common Stock and a stock option for 1,078 shares with a specified vesting schedule and a $507.56 per share exercise price.
How many MDGL restricted stock units were granted to John C. Reed and how do they vest?
John C. Reed was granted 647 restricted stock units of MDGL Common Stock. These RSUs vest 50% on August 15, 2027 and 50% on August 15, 2028, provided he continues in service with Madrigal Pharmaceuticals on each applicable vesting date.
What are the key terms of John C. Reed’s MDGL stock option grant?
He received a stock option for 1,078 shares of MDGL Common Stock at an exercise price of $507.56 per share, expiring on August 15, 2036, with vesting tied to continued service over time.
What is the vesting schedule for John C. Reed’s MDGL stock option award?
The option vests 50% on August 15, 2027. The remaining shares vest in four installments of 12.5% each on the last day of successive three-month periods, contingent on his continued service with Madrigal Pharmaceuticals.
Are John C. Reed’s reported MDGL equity awards immediately vested?
No. The 647 RSUs vest 50% in 2027 and 50% in 2028, and the 1,078-share stock option vests 50% in 2027 and then 12.5% quarterly for four periods, all subject to his continued service with Madrigal Pharmaceuticals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
